Both simvastatin and metformin can prompt improvements in women with polycystic ovary syndrome (PCOS) but simvastatin seems to have a stronger effect, new research suggests.…

Maggots are an effective, low-cost salvage option to debride poorly vascularized, infected wounds in patients with diabetes, especially when vascular remediation is not possible….

Tight glucose control won’t mitigate the cognitive effects of type 2 diabetes, an ACCORD subanalysis found.…

A new interactive mobile phone app called DiabetesIQ, released this week, challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease.…

Two new studies into the potential health benefits of eating almonds have supported evidence that they can help people with type 2 diabetes to maintain their blood glucose and cholesterol levels.…

A new research review confirms that people with diabetes have a somewhat increased risk of colon cancer — but the reasons for the connection, and what should be done about it, remain unclear….

The results show that salsalate is effective in improving glycemic control in newly diagnosed naive patients with type 2 diabetes.…

Novo Nordisk has filed for regulatory approval of the ultra-long-acting insulins Degludec and DegludecPlus in Europe. According to their press release Novo will also be submitting both drugs to the FDA within two weeks. Both drugs will be available with a pen delivery system.

More and more of our patients are developing diabetes, many of them at a much earlier age, so treatment has to be more focused and intense: the sooner this starts the better. This Special Edition brings you the background and basis for starting insulin therapy earlier. Two leading endocrinologists, Dr. …

Diabetes In Control staff contacted several physicians all across the US to find out what they had to say about early insulin initiation. What they said may surprise you….